Lagreca Eye Clinic And Surgery Center is categorized under Ophthalmologists in Sandpoint, ID and active since 1958.
Lagreca Eye Clinic And Surgery Center was established in 1958, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Ophthalmologists business, which does work in the B2C market, and is classified as a Ophthalmologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Brian Lagreca at the company’s single location by writing to 307 South 1st Avenue, Sandpoint, Idaho ID 83864 or by phoning (208) 263-8501. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Lagreca Eye Clinic And Surgery Center |
Contact Person: | Brian Lagreca |
Address: | 307 South 1st Avenue, Sandpoint, Idaho 83864 |
Phone Number: | (208) 263-8501 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1958 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Ophthalmologists |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Lagreca Eye Clinic And Surgery Center was started in 1958 to provide professional Ophthalmologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Brian Lagreca for inquiries that concern Lagreca Eye Clinic And Surgery Center by calling the company number (208) 263-8501, as your correspondence is most welcome. Additionally, the physical location of the single location of Lagreca Eye Clinic And Surgery Center can be found at the coordinates 48.270689,-116.547586 as well as the street address 307 South 1st Avenue in Sandpoint, Idaho 83864.
For its online presence, you may visit Lagreca Eye Clinic And Surgery Center’s website at and engage with its social media outlets through on Twitter and on Facebook.